KISS1 and breast carcinoma: These studies point to a possible stratification of breast cancer with regards to the effect of kisspeptin into an oestrogen receptor-positive group where kisspeptin acts in an anti-metastatic manner, and an oestrogen receptor-negative group where it acts in a pro-metastatic manner.